4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-026692
EVP and Chief Medical Officer acquired 4,658 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crombez Eric EVP and Chief Medical Officer | 2023-05-01 | Grant or award | +4,658 | 30,512 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crombez Eric EVP and Chief Medical Officer | 2023-05-01 | Grant or award · Stock Option (Right to Buy) | +8,362 | 8,362 | D: show line 2 in the form |
Loading xslF345X04/doc4.xml…